Verzenio
Active substance: abemaciclib
TABLET · ABEMACICLIB 150 mg/1
United StatesActive
Marketing holder: Eli Lilly and Company
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- ABEMACICLIB · 150 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-a238-74bf-b8be-e85221f74421,01a1208e-cd3f-78be-896c-e7d1d622828c,01a1208e-e057-7420-ad98-1e346f76625a,01a1208e-fe2c-7076-8327-7c5a539aeff2;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0002-5337
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0002-5337 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0002-5337 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0002-5337 · Verified 2026-10-09 · open in source